The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Circulating miRNA Biomarkers for Alzheimer's Disease
Open accessAbstract
A minimally invasive diagnostic assay for early detection of Alzheimer's disease (AD) is required to select optimal patient groups in clinical trials, monitor disease progression and response to treatment, and to better plan patient clinical care. Blood is an attractive source for biomarkers due to minimal discomfort to the patient, encouraging greater compliance in clinical trials and frequent testing. MiRNAs belong to the class of non-coding regulatory RNA molecules of ∼22 nt length and are now recognized to regulate ∼60% of all known genes through post-transcriptional gene silencing (RNAi). They have potential as useful biomarkers for clinical use because of their stability and ease of detection in many tissues, especially blood. Circulating profiles of miRNAs have been shown to discriminate different tumor types, indicate staging and progression of the disease and to be useful as prognostic markers. Recently their role in neurodegenerative diseases, both as diagnostic biomarkers as well as explaining basic disease etiology has come into focus. Here we report the discovery and validation of a unique circulating 7-miRNA signature (hsa-let-7d-5p, hsa-let-7g-5p, hsa-miR-15b-5p, hsa-miR-142-3p, hsa-miR-191-5p, hsa-miR-301a-3p and hsa-miR-545-3p) in plasma, which could distinguish AD patients from normal controls (NC) with >95% accuracy (AUC of 0.953). There was a >2 fold difference for all signature miRNAs between the AD and NC samples, with p-values<0.05. Pathway analysis, taking into account enriched target mRNAs for these signature miRNAs was also carried out, suggesting that the disturbance of multiple enzymatic pathways including lipid metabolism could play a role in AD etiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gupta, A., Nagilla, P., Le, H.-S., Bunney, C., Zych, C., Thalamuthu, A., Bar‐Joseph, Z., Mathavan, S., & Ayyavoo, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022730 · Cited by 52
RetractedModern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 1×
“Another important study supporting the ability of exosomes to cross the blood brain barrier was recently published, in which researchers engineered mouse dendritic cell derived exosomes to target neurons by the RGV peptide, and achieved ,60% reduction of BACE1 mRNA and protein using RNAi in the mouse brain [80].”
BackgroundTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
Direct multiplexed measurement of gene expression with color-coded probe pairs
Geiss, G. K., Bumgarner, R. E., Birditt, B., Dahl, T., Dowidar, N., Dunaway, D. L., Fell, H. P., Ferree, S., George, R. D., Grogan, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1385 · Cited by 2,066
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 1×
“There was also evidence from multiple GWAS studies, that ApoE [92], Clu [93] and ABCA7 [94] gene polymorphisms were associated with AD and furthermore there was also biochemical data directly implicating lipid metabolism in both amyloid and tau pathology [95].”
ResultCharacterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941
Krämer, W. (2003) · Computational Statistics & Data Analysis · Cited by 1,858
MicroRNA profiling: approaches and considerations
Pritchard, C. C., Cheng, H. H., & Tewari, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3198 · Cited by 1,765
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180 · cited 1×
“Another source of biomarkers that has been the focus of attention of researchers, especially in cancer biology and cardiovascular diseases is blood [16] [17] [18].”
BackgroundA novel and universal method for microRNA RT-qPCR data normalization
Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., & Vandesompele, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-6-r64 · Cited by 1,079 · cited 1×
“The globalmean of top-100 miRNA expressers in the samples tested was used to content normalize the miRNA expression across all samples as described previously [63][64].”
MethodThe majority of microRNAs detectable in serum and saliva is concentrated in exosomes
Gallo, A., Tandon, M., Alevizos, I., & Illei, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030679 · Cited by 1,060
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 1×
“In addition, a panel of signaling proteins in the plasma was also described to predict AD phenotype, suggesting that it is conceivable that a compromised blood-brain barrier in AD and other neurodegenerative disorders, will allow the exchange of molecules between the CNS and the periphery [73] [74].”
BackgroundExport of microRNAs and microRNA-protective protein by mammalian cells
Wang, K., Zhang, S., Weber, J., Baxter, D., & Galas, D. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq601 · Cited by 1,002
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · cited 1×
“Of particular interest were expression patterns of hsa-miR-9 and hsa-miR-132, which based on their known (and predicted targets) were linked to the alterations in stem cell commitment, neuronal differentiation and actin remodeling [57].”
BackgroundAn Analysis of Human MicroRNA and Disease Associations
Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W., & Cui, Q. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003420 · Cited by 902
Tapiola, T., Alafuzoff, I., Herukka, S.-K., Parkkinen, L., Hartikainen, P., Soininen, H., & Pirttilä, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.596 · Cited by 896
Characterization of microRNA expression profiles in normal human tissues.
Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-166 · Cited by 881
Mason, S. J., & Graham, N. E. (2002) · Quarterly Journal of the Royal Meteorological Society · doi:10.1256/003590002320603584 · Cited by 868
Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764
Michael, A., Bajracharya, S., Yuen, P., Zhou, H., Star, R., Illei, G., & Alevizos, I. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2009.01604.x · Cited by 724
Barthel, H., Gertz, H.-J., Dresel, S., Peters, O., Bartenstein, P., Buerger, K., Hiemeyer, F., Wittemer-Rump, S. M., Seibyl, J., Reininger, C., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70077-1 · Cited by 591
Buerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., DeBernardis, J., Kerkman, D., McCulloch, C., Soininen, H., et al. (2006) · Brain · doi:10.1093/brain/awl269 · Cited by 586
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20712 · Cited by 567
Identifying and validating biomarkers for Alzheimer's disease
Humpel, C. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.09.007 · Cited by 484 · cited 1×
“Unfortunately, both tau and p-tau cannot be used to correctly identify AD since changes of these molecules have also been implicated in other neurodegenerative diseases [15].”
BackgroundSuh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo
Fulga, T. A., Elson-Schwab, I., Khurana, V., Steinhilb, M. L., Spires, T. L., Hyman, B. T., & Feany, M. B. (2007) · Nature Cell Biology · doi:10.1038/ncb1528 · Cited by 452 · cited 1×
“Furthermore, supporting the tau hypothesis, it has recently been proposed that tau may mediate neurotoxicity by altering the organization and dynamics of the actin cytoskeleton [90].”
BackgroundGraff-Radford, N. R., Crook, J. E., Lucas, J., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C., & Younkin, S. G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.354 · Cited by 441
Bellingham, S. A., Coleman, B. M., & Hill, A. F. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks832 · Cited by 440
Alonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437
Liu, R., Zhang, C., Hu, Z., Li, G., Wang, C., Yang, C., Huang, D., Chen, X., Zhang, H., Zhuang, R., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.025 · Cited by 408
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., & Beal, M. F. (2008) · Brain · doi:10.1093/brain/awm304 · Cited by 401
Circulating microRNAs in breast cancer and healthy subjects
Zhu, W., Qin, W., Atasoy, U., & Sauter, E. R. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-89 · Cited by 359
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
Yu, L., Todd, N. W., Xing, L., Xie, Y., Zhang, H., Liu, Z., Fang, H., Zhang, J., Katz, R. L., & Jiang, F. (2010) · International Journal of Cancer · doi:10.1002/ijc.25289 · Cited by 353
Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
Hanash, S. M., Baik, C. S., & Kallioniemi, O. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.220 · Cited by 328
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
Kocerha, J., Faghihi, M. A., Lopez-Toledano, M. A., Huang, J., Ramsey, A. J., Caron, M. G., Sales, N., Willoughby, D., Elmen, J., Hansen, H. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805854106 · Cited by 295
Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease
Geekiyanage, H., Jicha, G. A., Nelson, P. T., & Chan, C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.026 · Cited by 294
Hansson, O., Zetterberg, H., Buchhave, P., Andreasson, U., Londos, E., Minthon, L., & Blennow, K. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100926 · Cited by 288
Emerging roles of exosomes in neuron-glia communication
Frühbeis, C., Fröhlich, D., & Krämer-Albers, E.-M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00119 · Cited by 275
Circulating microRNAs in plasma as early detection markers for breast cancer
Cuk, K., Zucknick, M., Heil, J., Madhavan, D., Schott, S., Turchinovich, A., Arlt, D., Rath, M., Sohn, C., Benner, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27799 · Cited by 266
Wiltfang, J., Esselmann, H., Bibl, M., Hüll, M., Hampel, H., Kessler, H., Frölich, L., Schröder, J., Peters, O., Jessen, F., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04404.x · Cited by 263
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., & Mayr, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr266 · Cited by 258
Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes
Weimer, D. L., & Sager, M. A. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.01.028 · Cited by 257
Malumbres, R., Sarosiek, K. A., Cubedo, E., Ruiz, J. W., Jiang, X., Gascoyne, R. D., Tibshirani, R., & Lossos, I. S. (2009) · Blood · doi:10.1182/blood-2008-10-184077 · Cited by 252
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., Grossman, M., Xiong, C., Craig-Schapiro, R., Clark, C. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318266fa70 · Cited by 241
MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
Lai, C.-Y., Yu, S.-L., Hsieh, M. H., Chen, C.-H., Chen, H.-Y., Wen, C.-C., Huang, Y.-H., Hsiao, P.-C., Hsiao, C. K., Liu, C.-M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021635 · Cited by 228 · cited 1×
“In schizophrenia, a seven-miRNA signature (hsamiR-34a, hsa-miR-449a, hsa-miR-564, hsa-miR-432, hsa-miR548d, hsa-miR-572 and hsa-miR-652) was identified in mononuclear leukocytes, which were found to be correlated with patients’ negative symptoms, neurocognitive performance scores, and event-related potentials [48].”
BackgroundLong, J. M., & Lahiri, D. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.053 · Cited by 209
Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Li, J., Wang, Y., Yu, W., Chen, J., & Luo, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.111 · Cited by 209
MicroRNAs can regulate human APP levels
Patel, N., Hoang, D., Miller, N., Ansaloni, S., Huang, Q., Rogers, J. T., Lee, J. C., & Saunders, A. J. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-10 · Cited by 204
A specific miRNA signature in the peripheral blood of glioblastoma patients
Roth, P., Wischhusen, J., Happold, C., Chandran, P. A., Hofer, S., Eisele, G., Weller, M., & Keller, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07307.x · Cited by 200
Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid
Vella, L. J., Greenwood, D. L. V., Cappai, R., Scheerlinck, J.-P. Y., & Hill, A. F. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.04.002 · Cited by 200
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
Mizuno, H., Nakamura, A., Aoki, Y., Ito, N., Kishi, S., Yamamoto, K., Sekiguchi, M., Takeda, S., & Hashido, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018388 · Cited by 198
Plasma microRNA biomarkers for detection of mild cognitive impairment
Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., & Umansky, S. R. (2012) · Aging · doi:10.18632/aging.100486 · Cited by 188
Yanamandra, K., Gruden, M. A., Casaite, V., Meskys, R., Forsgren, L., & Morozova-Roche, L. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018513 · Cited by 171
Lin, L., Lesnick, T. G., Maraganore, D. M., & Isacson, O. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.006 · Cited by 164
Schwarz, E., Izmailov, R., Spain, M., Barnes, A., Mapes, J. P., Guest, P. C., Rahmoune, H., Pietsch, S., Leweke, F. M., Rothermundt, M., et al. (2010) · Biomarker Insights · doi:10.4137/bmi.s4877 · Cited by 160
Alzheimer's disease: early diagnosis and treatment.
Chu, L. (2012) · PubMed · Cited by 147
SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
Shehadeh, L. A., Yu, K. M., Wang, L., Guevara, A., Singer, C., Vance, J. M., & Papapetropoulos, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009104 · Cited by 132
Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
Thambisetty, M., Simmons, A., Hye, A., Campbell, J., Westman, E., Zhang, Y., Wahlund, L., Kinsey, A. M., Čaušević, M., Killick, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028527 · Cited by 131
MicroRNA dysregulation in colorectal cancer: a clinical perspective
Dong, Y., Wu, W. K. K., Wu, C. W., Sung, J. J. �., Yu, J. Q., & Ng, S. S. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.57 · Cited by 131
α1-Antitrypsin and α1-antichymotrypsin are in the lesions of Alzheimerʼs disease
Gollin, P. A., Kalaria, R. N., Eikelenboom, P., Rozemüller, A. J. M., & Perry, G. L. (1992) · Neuroreport · doi:10.1097/00001756-199202000-00020 · Cited by 124
Laganà, A., Forte, S., Giudice, A., Arena, M. R., Puglisi, P. L., Giugno, R., Pulvirenti, A., Shasha, D. E., & Ferro, A. (2009) · Database · doi:10.1093/database/bap008 · Cited by 110
Clathrin-mediated endocytosis and Alzheimer's disease: An update
Wu, F., & Yao, P. J. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.002 · Cited by 107
Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
Imbimbo, B. P., Ottonello, S., Frisardi, V., Solfrizzi, V., Greco, A., Seripa, D., Pilotto, A., & Panza, F. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.93 · Cited by 105
Computational Challenges in miRNA Target Predictions: To Be or Not to Be a True Target?
Barbato, C., Arisi, I., Frizzo, M. E., Brandi, R., Sacco, L. D., & Masotti, A. (2009) · BioMed Research International · doi:10.1155/2009/803069 · Cited by 102
Głodzik-Sobańska, L., Pirraglia, E., Bryś, M., Santi, S. D., Mosconi, L., Rich, K. E., Switalski, R., Louis, L. S., Sadowski, M. J., Martiniuk, F. T., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.019 · Cited by 95
Comprehensive analysis of human microRNA target networks
Satoh, J., & Tabunoki, H. (2011) · BioData Mining · doi:10.1186/1756-0381-4-17 · Cited by 82
Can Statins Prevent or Help Treat Alzheimer's Disease?
McGuinness, B., & Passmore, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091570 · Cited by 73
Identification of microRNA-mRNA modules using microarray data
Jayaswal, V., Lutherborrow, M. A., David, D. F., & Yang, J. Y. H. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-138 · Cited by 70
MicroRNAs and Alzheimer′s Disease Mouse Models: Current Insights and Future Research Avenues
Delay, C., & Hébert, S. S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/894938 · Cited by 68
Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray data
Pelz, C., Kulesz-Martin, M. F., Bagby, G. C., & Sears, R. C. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-520 · Cited by 67
Regulation of cytokines by small RNAs during skin inflammation
Bak, R. O., & Mikkelsen, J. G. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-53 · Cited by 58
Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease
Liao, P., Yu, L., Kuo, C., Lin, C., & Kuo, Y. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200600684 · Cited by 55
Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab
Panza, F., Frisardi, V., Imbimbo, B. P., Seripa, D., Paris, F., Santamato, A., D’Onofrio, G., Logroscino, G., Pilotto, A., & Solfrizzi, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511798192718 · Cited by 54
Plasma Biomarkers for Alzheimer’s Disease: Much Needed But Tough to Find
Bazenet, C. E., & Lovestone, S. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.48 · Cited by 51
Noelker, C., Hampel, H. J., & Dodel, R. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256398 · Cited by 32
Chacon, P. J., Garcia-Mejias, R., & Rodriguez-Tebar, A. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-14 · Cited by 28
Tau is actin up in Alzheimer's disease
Gallo, G. (2007) · Nature Cell Biology · doi:10.1038/ncb0207-133 · Cited by 25
Piccini, A. (2010) · The Open Nuclear Medicine Journal · doi:10.2174/1876388x01002010025 · Cited by 1
Cited by
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
MicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
Methodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436
Cheng, L., Doecke, J. D., Sharples, R. A., Villemagne, V. L., Fowler, C. J., Rembach, A., Martins, R. N., Rowe, C. C., Macaulay, S. L., Masters, C. L., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.127 · Cited by 409
Metadata
- Authors
- Kumar, P., Dezso, Z., MacKenzie, C., Oestreicher, J., Agoulnik, S., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., & Oda, Y.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-29
- Volume
- 8
- Issue
- 7
- Pages
- e69807
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2057082801
- Cited by
- 381
- References
- 98
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.